FHCCX Fees and Costs — Fidelity Advisor Health Care Fund, Class C
Data updated: 2026-10-13
The net expense ratio is 1.71%: a 0.66% management fee, a 1.00% 12b-1 fee plus 0.05% other expenses. This share class carries a deferred sales charge of up to 1.00%. In fiscal 2026 the fund paid $1.2M in broker commissions, 0.0373% of average net assets, and portfolio turnover was 74%.
FHCCX Fees and Expenses
Annual operating expenses and sales charges of FHCCX. Prospectus, as of September 29, 2026.
| Annual operating expenses | |
|---|---|
| Management fee | 0.66% |
| 12b-1 fee | 1.00% |
| Other expenses | 0.05% |
| Gross expense ratio | 1.71% |
| Fee waiver | — |
| Net expense ratio | 1.71% |
| Sales charges | |
|---|---|
| Max front load | 0.00% |
| Max deferred load | 1.00% |
| Redemption fee | — |
FHCCX Costs Over Time
On $10,000 invested in FHCCX, assuming 5% a year before costs, total costs come to $1,077 over 5 years, cutting the return by 1.83% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $103 | $0 | $0 |
| Fund expenses (net expense ratio 1.71%) | $180 | $556 | $956 |
| Trading costs (broker commissions) | $4 | $12 | $21 |
| Lost growth on money paid in costs | $0 | $28 | $99 |
| Total costs | $287 | $596 | $1,077 |
| Value after costs | $10,213 | $10,980 | $11,686 |
| Impact on return, per year | 2.87% | 1.83% | 1.83% |
FHCCX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending July 31, 2026.
- Explicit cost rate (commissions ÷ average net assets): 0.0373%
- Total broker commissions: $1.2M
- Bought from dealers (principal trades, not a cost): $79.3M
- Portfolio turnover (prospectus): 74%
FHCCX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| GOLDMAN SACHS GROUP INC (THE) | $126K | 14.30% |
| JPMORGAN CHASE and CO | $124K | 14.13% |
| JEFFERIES FINANCIAL GROUP INC | $116K | 13.23% |
| CITIGROUP INC | $110K | 12.46% |
| UBS GROUP AG | $103K | 11.68% |
| BANK OF AMERICA CORPORATION | $97K | 10.98% |
| MORGAN STANLEY | $85K | 9.62% |
| THE TORONTO DOMINION BANK | $52K | 5.92% |
| VIRTU FINANCIAL INC | $34K | 3.90% |
| CONDOR TRADING LLC | $33K | 3.78% |
FHCCX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| JEFFERIES FINANCIAL GROUP INC | $25.8M | 32.49% |
| MORGAN STANLEY | $15.4M | 19.43% |
| JPMORGAN CHASE and CO | $12.3M | 15.50% |
| GOLDMAN SACHS GROUP INC (THE) | $8.2M | 10.35% |
| LEERINK PARTNERS LLC | $6.4M | 8.01% |
| THE TORONTO DOMINION BANK | $5.6M | 7.08% |
| BANK OF AMERICA CORPORATION | $4.6M | 5.82% |
| PIPER SANDLER COS | $1.0M | 1.31% |
Fidelity Advisor Health Care Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| FIKCX | Class Z | 0.59% | none |
| FHCIX | Class I | 0.71% | none |
| FACDX | Class A | 0.96% | 5.75% |
| FACTX | Class M | 1.21% | 3.50% |
| FHCCX | Class C | 1.71% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.